The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans
- PMID: 21956416
- PMCID: PMC3232609
- DOI: 10.1210/jc.2011-1497
The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans
Abstract
Objective: The aim of the study was to investigate the associations between IL-1 receptor antagonist (IL-1RA), IL-6, IL-10, measures of obesity, and insulin resistance in African-Americans.
Research design and methods: Nondiabetic participants (n = 1025) of the Howard University Family Study were investigated for associations between serum IL (IL-1RA, IL-6, IL-10), measures of obesity, and insulin resistance, with adjustment for age and sex. Measures of obesity included body mass index, waist circumference, hip circumference, waist-to-hip ratio, and percent fat mass. Insulin resistance was assessed using the homeostasis model assessment of insulin resistance (HOMA-IR). Data were analyzed with R statistical software using linear regression and likelihood ratio tests.
Results: IL-1RA and IL-6 were associated with measures of obesity and insulin resistance, explaining 4-12.7% of the variance observed (P values < 0.001). IL-1RA was bimodally distributed and therefore was analyzed based on grouping those with low vs. high IL-1RA levels. High IL-1RA explained up to 20 and 12% of the variance in measures of obesity and HOMA-IR, respectively. Among the IL, only high IL-1RA improved the fit of models regressing HOMA-IR on measures of obesity. In contrast, all measures of obesity improved the fit of models regressing HOMA-IR on IL. IL-10 was not associated with obesity measures or HOMA-IR.
Conclusions: High IL-1RA levels and obesity measures are associated with HOMA-IR in this population-based sample of African-Americans. The results suggest that obesity and increased levels of IL-1RA both contribute to the development of insulin resistance.
References
-
- Fève B, Bastard JP. 2009. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 5:305–311 - PubMed
-
- Taubes G. 2009. Prosperity's plague. Science 325:256–260 - PubMed
-
- Khan LK, Sobush K, Keener D, Goodman K, Lowry A, Kakietek J, Zaro S. 2009. Recommended community strategies and measurements to prevent obesity in the United States. Morbidity and mortality weekly report. Recommendations and reports. Atlanta: Centers for Disease Control and Prevention; 1–26 - PubMed
-
- Pan L, Galuska DA, Sherry B, Hunter AS, Rutledge GE, Deitz WH, Balluz LS. 2009. Differences in prevalence of obesity among black, white and Hispanic adults—United States, 2008. Morbidity and mortality weekly report. Atlanta: Centers for Disease Control and Prevention; 740. –744
-
- Juge-Aubry CE, Henrichot E, Meier CA. 2005. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 19:547–566 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
